Nationales Centrum für Tumorerkrankungen Heidelberg erneut als selbsthilfefreundlich ausgezeichnet - Krebs-Nachrichten
Studienleitgruppe – GMMG Studiengruppe
Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myeloma - Kriegsmann - 2018 - Cytometry Part B: Clinical Cytometry - Wiley Online Library
Moderne Molekulare Diagnostik beim Multiplen Myelom
Dirk HOSE | Professor of Medicine (10% ZAP) | Prof. Dr. med. Dr. biol. hom. | Vrije Universiteit Brussel, Brussels | VUB | Hematology (HEIM) - Page 13
Südkoreanische Krebsforscher und Politiker zu Gast am NCT Heidelberg - NCT Nationales Centrum für Tumorerkrankungen Heidelberg
Is precision medicine a bust in myeloma? | VJHemOnc
Heidelberg Myeloma Workshop | DKG
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell ...
Myeloma Crowd Radio: Drs. Anja Seckinger and Dirk Hose, University of Heidelberg 05/24 by Myeloma Crowd Radio | Health
Universitätsklinikum Heidelberg: CLIOMMICS
/tmp/2/2/3/8/ca17-2b39-4755-960d-e6dd7202aede "Myeloma Crowd Radio: Drs. Anja Seckinger and Dirk Hose, University of Heidelberg by Myeloma Crowd Radio | Mixcloud")
Myeloma Crowd Radio: Drs. Anja Seckinger and Dirk Hose, University of Heidelberg by Myeloma Crowd Radio | Mixcloud
Kollegium - St. Raphael Gymnasium in Heidelberg
ISSW - Gratulation zur Habilitation an Dr. Marie Ottilie Frenkel! Nach ihrem heutigen Vortrag zum sportpsychologischen Training im Leistungssport wurde ihr von Dekan Prof. Dr. Dirk Hagemann die Urkunde zur Venia Legendi
Dr. med. Hose, Innere Medizin in Heidelberg | sanego
Loop | Dirk Hose
Dirk Hose, CMO
MTB Schreinerei GmbH, 68535 Edingen
Heidelberg Myeloma Workshop | DKG
Stored and Cooled Ions Division - Division Members
Dr. med. Hose, Innere Medizin in Heidelberg | sanego
Dirk Hose, CMO
Frontiers | CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma—Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance | Immunology
Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma | Leukemia
Sportliche 55.000 Euro für das KiTZ - KiTZ
Press Release | Heidelberg
